14.400
+3,60%
2026-10-19
Fundamental Analysis
15 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -118.1% | -69.9% | 0 / 3 | -47.9% | -43.80 pp | -47.25 pp | +5.8% | 0.00 | 21.86 | 17,4 | −47,9% | −2,1 | −118,1% | 21.86 | 16.60 | +31,7% |
| Pts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 14.400 (close price on 2026-10-19)EPS (TTM): 658,7
Financial charts
1.Revenue & growth
VND bn17,4Q2/26
1.Revenue & growth
VND bn17,4Q2/26
2.Profit & growth
VND bn-2,12Q2/26
3.Profit mix (Penman)
VND bn26,3Q2/26
4.Margins & cost structure
%39.5%Q2/26
5.Returns & cash cycle
% · days6.1%Q2/26
6.Earnings quality & cash
VND bn57,9Q2/26
7.Asset structure
VND bn398Q2/26
8.Funding & debt health
VND bn · times398Q2/26
9.Revenue backlog
VND bn0,00Q2/26
10.Valuation
times · %21,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-64Q2/26
Adjusted EPS growth, latest quarter
-118%
Average adjusted EPS growth, 3 quarters
-69.9%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26